The Epidemiology and Pathogenesis of Kawasaki Disease
Top Cited Papers
Open Access
- 11 December 2018
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 6, 374
- https://doi.org/10.3389/fped.2018.00374
Abstract
Epidemiologic and clinical features of Kawasaki Disease (KD) strongly support an infectious etiology. KD is worldwide, most prominently in Japan, Korea, and Taiwan, reflecting increased genetic susceptibility among Asian populations. In Hawaii, KD rates are 20-fold higher in Japanese ethnics than in Caucasians, intermediate in other ethnicities. The age distribution of KD, highest in children < 2 yo, lower in those < 6 months, is compatible with infection by a ubiquitous agent resulting in increasing immunity with age and with transplacental immunity, as with some classic viruses. The primarily winter-spring KD seasonality and well-documented Japanese epidemics with wave-like spread also support an infectious trigger. We hypothesize KD pathogenesis involves an RNA virus that usually causes asymptomatic infection but KD in a subset of genetically predisposed children. CD8 T cells, oligoclonal IgA, and upregulation of cytotoxic T cell and interferon pathway genes in the coronaries in fatal KD also support a viral etiology. Cytoplasmic inclusion bodies in ciliated bronchial epithelium identified by monoclonal antibodies made from oligoclonal IgA heavy chains also supports a viral etiology. Recent availability of “second generation” antibodies from KD peripheral blood plasmablasts may identify a specific viral antigen. Thus, we propose an unidentified (“new”) RNA virus infects bronchial epithelium usually causing asymptomatic infection but KD in a subset of genetically predisposed children. The agent persists in inclusion bodies, with intermittent respiratory shedding, entering the bloodstream via macrophages targeting coronaries. Antigen-specific IgA plasma cells and CD8 T cells respond but coronaries can be damaged. IVIG may include antibody against the agent. Post infection, 97–99% of KD patients are immune to the agent, protected against recurrence. The agent can spread either from those with asymptomatic primary infection in winter-spring or from a previously infected contact who intermittently sheds the agent.Keywords
This publication has 27 references indexed in Scilit:
- Kawasaki Disease in Monozygotic TwinsThe Pediatric Infectious Disease Journal, 2011
- Ultrastructural, Immunofluorescence, and RNA Evidence Support the Hypothesis of a “New” Virus Associated With Kawasaki DiseaseThe Journal of Infectious Diseases, 2011
- Hospitalizations for Kawasaki Syndrome Among Children in the United States, 1997–2007The Pediatric Infectious Disease Journal, 2010
- RNA-Containing Cytoplasmic Inclusion Bodies in Ciliated Bronchial Epithelium Months to Years after Acute Kawasaki DiseasePLOS ONE, 2008
- Detection of Antigen in Bronchial Epithelium and Macrophages in Acute Kawasaki Disease by Use of Synthetic AntibodyThe Journal of Infectious Diseases, 2004
- CD8 T Lymphocytes and Macrophages Infiltrate Coronary Artery Aneurysms in Acute Kawasaki DiseaseThe Journal of Infectious Diseases, 2001
- IgA Plasma Cell Infiltration of Proximal Respiratory Tract, Pancreas, Kidney, and Coronary Artery in Acute Kawasaki DiseaseThe Journal of Infectious Diseases, 2000
- An Outbreak of Kawasaki Disease in Miyako Island in Okinawa PrefecturePediatrics International, 1983
- An epidemic of Kawasaki syndrome in HawaiiThe Journal of Pediatrics, 1982
- Kawasaki Syndrome: Description of Two Outbreaks in the United StatesNew England Journal of Medicine, 1981